FosamaxMDL1789-Calendar

In re Fosamax Products Liability Litigation, MDL No. 1789

MDL No. 1789

Court Calendar

U.S. District Court calendar related to all pending cases in In re Fosamax Products Liability Litigation, MDL No. 1789 (S.D.N.Y.).

Date

Time

Subject

10/07/06

Any case subject to a conditional transfer order on or prior to this date is eligible for inclusion in the early trial pool.

01/29/07

9:30am

Status conference with Magistrate Judge Francis

(subject: initial meeting with Magistrate)

11:30am

Status conference with Judge Keenan

(subject: trial selection process)

02/19/07

PPF's due for all potential early trial cases.

04/13/07

PSC expert reports on class certification issues due.

05/11/07

Merck expert reports on class certification issues due.

05/21/07

Deadline to review potential early trial cases. Merck selects 12 (and sends to PSC via U.S. mail postmarked on this date), PSC selects 12 (and sends to Merck via U.S. mail postmarked on this date), Court selects 1.

06/01/07

Deposition of Dr. Robert Marx, Miami, Florida.

06/14/07

Deposition of Paul Mulholland, CPA.

06/14/07

Deposition of Dr. Alistair Goss, Melbourne, Australia.

07/12/07

Deposition of Merck's expert, Jeri Nieves, Ph.D.

07/17/07

Deposition of Merck's expert, John Bilezikian, M.D.

07/19/07

Deposition of Merck's expert, Paul A. Bartlett, Ph.D.

07/20/07

Deadline to complete expert discovery on class certification issues.

07/30/07

Deposition of Merck's expert, Robert Glickman, D.M.D.

08/10/07

PSC class certification brief due.

09/10/07

Merck class certification brief due (hearing to be set in September 2007).

11/30/07

Dental Monitoring Class Certification Hearing

03/28/08

Deposition of Anastasia Daifotis, V.P. of Clinical Research, Merck Research Labs, New York

04/09/08

Informational Meeting for MDL Plaintiffs' Counsel, 3:00 p.m. PT, Alsace 2, Wynn Las Vegas Resort & Casino (limited solely to those counsel with plaintiffs' cases pending in the Fosamax MDL). For additional information, email Jessica Bohon atjbohon [at] levinlaw [dot] com or Tim O'Brien tobrien [at] levinlaw [dot] com

05/07/08

Deposition of Art Santora, Executive Director, Clinical Research, Merck Research Labs, New York

05/20/08

2nd Day of Depo. of Art Santora, Executive Director, Clinical Research, Merck Research Labs, New York

05/29/08

Deposition of Donald B. Kimmel, D.D.S., Ph.D., Director, Molecular Endocrinology, Merck Research Labs, Warrington, PA

06/02/08

10:00 a.m., Hearing on PSC Motion to Compel, Judge Keenan

07/25/08

9:30am

Discovery status conference with Magistrate Judge Francis, Courtroom 18D

08/28/08

Deposition of Michelle Flicker, M.D., Ph.D., Director, Regulatory Affairs, Merck & Co., New York

09/24/08

Deposition of Dr. Michael Goldberg, former Senior Director of Worldwide Product Safety & Epidemiology., Philadelphia

09/26/08

9:00am

Discovery Status Conference with Magistrate Judge Francis

10/01/08

Case-specific fact discovery deadline for the 25 early trial eligible cases. Thereafter, PSC selects 1, Merck selects 1, and Court selects 1, for early trial.

10/16/08

10:30am Courtroom 20C

Case Management Conference with District Court to address proposed CMOs relating to schedule to complete all generic expert discovery in this MDL and for summary judgment motions

11/12/08

Discovery Status Conference with Magistrate Judge Francis, 9:30 a.m.

12/04/08

2nd day of Deposition of Dr. Michael Goldberg, former Senior Director of Worldwide Product Safety & Epidemiology, San Francisco

POSTPONED

Deposition of Bruce Psaty, M.D., Ph.D

01/16/09

Discovery Status Conference with Magistrate Judge Francis

01/22/09

01/23/09

Plaintiff's Rule 26(a)(2) Expert Disclosures Due

01/30/09

Deposition of Georgianna Harris, Ph.D., Director, Regulatory Affairs, Merck & Co., New York

02/09/09

Deposition of Christiane Arsever, M.D., Associate Director, Medical Services, Merck & Co., Philadelphia

02/13/09

Deposition of Ms. Ellen Westrick, Executive Director, Office of Medical/Legal, Merck & Co., Naples, FL

02/16/09

Deposition of Alfred Reszka, Ph.D., Researcher, Department of Molecular Endocrinology and Bone Biology, Merck Research Labs., Philadelphia

02/19/09

Deposition of Peter Gruer, M.D., former Director, Worldwide Product Safety & Epidemiology., Philadelphia

02/19/09

Deposition of Dr. Frank Seebach, Director, Regulatory Affairs, Merck & Co., New York

02/20/09

Defendant's Rule 26(a)(2) Expert Disclosures Due

02/24/09

Deposition of Philip Ross, M.D., Senior Director and Acting Head, Medical Communications Department, Merck & Co., New York

02/26/09

Deposition of Anne DePapp, Executive Scientific Director, Merck Human Health Division, Philadelphia

02/26/09

Deposition of Patrick Counihan, Vice President of Health Care Systems, Merck & Co., Philadelphia

03/04/09

Deposition of Jack Gotcher, DMD, Ph.D., Knoxville, TN

03/04/09

Deposition of Daniel Baran, M.D., Senior Medical Director, Merck & Co., Philadelphia

03/05/09

Deposition of Patrick Magri, Vice President of Marketing, Merck & Co., Philadelphia

03/05/09

Deposition of Ms. Linda Hostelley, Vice President Worldwide Product Safety & Quality Assurance, Merck & Co., Philadelphia

03/09/09

Deposition of Dr. Gordon Guyatt, Hamilton, Ontario

03/12/09

Deposition of Suzanne Parisian, M.D., Phoenix, Arizona

03/16/09

Deposition of Curt D. Furberg, M.D., Washington, D.C.

03/17/09

Deposition of Mahyar Etminan, Pharm.D., M.Sc. (epidemiology), Vancouver, British Columbia

03/20/09

Discovery Status Conference with Magistrate Judge Francis, 2 p.m.

03/23/09

Deposition of Mary Ellen Fiore, CRMSS Associate, Merck & Co., Philadelphia

03/24/09

Discovery deposition of Alastair Goss, DDSc, Adelaide, Australia.

03/25/09

Deposition of John Hellstein, DDS, M.Sc., Iowa City, IA

03/25/09

Deposition of Nancy Santanello, MD, MS, Executive Director, Department of Epidemiology, Merck Research Labs, Philadelphia

03/26/09

Trial deposition of Alastair Goss, DDSc, Adelaide, Australia.

03/26/09

Deposition of Christine Peverly, Clinical Research, Merck Research Labs, New York City

03/27/09

Deposition of Robert Marx, DDS, Miami, FL

03/31/09

Deposition of Thomas Bold MD, Senior Director, Clinical Risk Management and Safety Surveillance, Merck Research Labs, Philadelphia

03/31/09

Deadline to complete MDL non-class discovery.

03/31/09

Depositions of Plaintiff's Experts Completed

04/03/09

Deposition of Scott Tomar, D.M.D., Ph.D., Gainesville, FL

04/10/09

Deposition of Jeri Nieves, Ph., New York City

04/13/09

Deposition of Robert Glickman, D.M.D., New York City

04/14/09

Deposition of Lisa Rarick, M.D., Washington, D.C.

04/15/09

Deposition of Ellen Eisenberg, D.M.D., Farmington, CT

04/17/09

Deposition of John Bilezikian, M.D., New York City

04/17/09

Deposition of Daniel Shames, M.D., Washington, D.C.

04/20/09

Deposition of Paul Barlett, Ph.D., Oakland, CA

04/22/09

Deposition of Michael McClung, M.D., Portland, OR

(CANCELLED AS MERCK WITHDREW EXPERT) 

04/24/09

Deposition of David Dempster, Ph.D., New York City

04/27/09

Deposition of James Adams, Associate Director, Worldwide Regulatory Affairs, Merck & Co., New York City.

04/28/09

Deposition of Elizabeth Holt, M.D., Ph.D., New York City

04/29/09

Deposition of Jane Cauley, Dr.PH, Pittsburgh, PA

04/30/09

Depositions of Defendant's Experts Completed

05/08/09

Daubert Motions Due; Dispositive Motions Due

06/08/09

Daubert Opposition Briefs Due; Dispositive Motions Opposition Briefs Due

06/18/09

Daubert Reply Briefs Due; Dispositive Motions Reply Briefs Due

07/08/09

Boles v. Merck & Co.: Motions in Limine Due

07/9-10/09

Daubert hearing before Judge Keenan

07/15/09

Boles v. Merck & Co.: Deposition Designations Exchanged

07/16/09

11:00am Courtroom 20-C

Summary judgment hearing in Shirley Boles v. Merck & Co., Inc.

07/20/09

Boles v. Merck & Co.: Exchange Portions of Pretrial Order (including exhibit and witness lists)

07/22/09

Boles v. Merck & Co.: Oppositions to Motions in Limine Due

07/28/09

Boles v. Merck & Co.: Joint Pretrial Order (including witness and exhibit lists) and Pretrial Memoranda Due

07/29/09

3:00 Courtroom 20-C

Boles v. Merck & Co.: Oral Arguments on Motions in Limine

07/29/09

Boles v. Merck & Co.: Deposition Counter-Designations and Objections Exchanged

08/06/09

Boles v. Merck & Co.: Deposition Counter-Counter-Designations and Objections Exchanged

08/10/09

Boles v. Merck & Co.: Premarked Exhibits and Proposed Voir Dire Questions to be Delivered to the Court

08/11/09

Boles v. Merck & Co.: Proposed Requests to Charge to be Delivered to the Court

08/11/09

Trial 1: Shirley Boles v. Merck & Co.

01/11/10

11:00am Courtroom 20-C

Summary judgment hearing in Maley trial case

02/01/10

11:00am Courtroom 20-C

Status Conference with Judge Keenan re selection of 3rd early trial case

03/04/10

Louise Maley v. Merck & Co.:  Motions in Limine Due

03/08/10

Louise Maley v. Merck & Co.:  Exchange Deposition Page and Line Designations

03/18/10

Louise Maley v. Merck & Co.:  Oppositions to Motions in Limine Due

03/25/10

Louise Maley v. Merck & Co.:  Reply Briefs re Motions in Limine Due

03/29/10

Louise Maley v. Merck & Co.: Exchange deposition Page and Line Counter-Designations

04/05/10

Louise Maley v. Merck & Co.: Exchange Objections and Counter-counter-Designations

04/06/10

Louise Maley v. Merck & Co.:  Pretrial Memoranda and Joint Pretrial Order Due

04/13/10

Parties to Notify Court if Hearing Needed on Objections to Depo Designations

04/18/10

Louise Maley v. Merck & Co.:  Electronic Exhibits to Court

04/19/10

Louise Maley v. Merck & Co.:  Proposed Voir Dire Questions and Proposed Requests to Charge Due   

04/19/10

Trial 2: Louise Maley v. Merck & Co.

05/27/10

4:00 p.m.

Motion in Limine Hearing

06/07/10

Retrial of Trial 1: Shirley Boles v. Merck & Co.

06/25/10

Graves v. Merck & Co.: Plaintiff's Rule 26(a)(2) Disclosures Due

07/26/10

Graves v. Merck & Co.: Defendant's Rule 26(a)(2) Disclosures Due

08/06/10

Graves v. Merck & Co.: Plaintiff's Expert Depo Deadline

08/25/10

Graves v. Merck & Co.: Defendant's Expert Depo Deadline

09/08/10

10:30a.m.
Courtroom 20-C

Oral Argument: Merck's Motions for New Trial in Boles v. Merck & Co.

09/10/10

Daubert Motions and Motions for Summary Judgment Due

09/17/10

Motions in Limine Due

09/24/10

Oppositions to Daubert and Motions for Summary Judgment Due

10/01/10

Replies to Daubert and Motions for Summary Judgment Due Oppositions to Motions in Limine Due

10/04/10

Graves v. Merck & Co.: Deposition Designations Due

10/08/10

Relies to Motions in Limine Due

10/12/10

Daubert and MSJ Hearing - 3:30p.m.

10/15/10

Exchange Draft Pretrial Order

10/18/10

Depo Counter-Designations and Objections Due

10/22/10

Joint Pretrial Order Due to Court Pretrial Memoranda Due to Court

10/25/10

Depo Counter-counter Designations and Objections Due Proposed Voir Dire Questions to Court

10/29/10

Electronic Exhibits to Court

11/01/10

Draft Jury Instructions to Court Trial

11/01/10

Trial 3: Judith Graves v. Merck & Co.

09/07/11

Trial 4:  Linda Secrest v. Merck & Co.

Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A.

316 South Baylen Street Suite 600

Pensacola, FL 32502-5996ph: (850) 435-7000 • toll free: (888) 435-7001 • fax: (850) 435-7020

For more information contact Fosamax Attorney tobrien [at] levinlaw [dot] com (subject: Fosamax%20MDL%20No.%201789) (Tim O'Brien)